Hadas, Ron
Rubinstein, Hernan
Mittnenzweig, Markus
Mayshar, Yoav
Ben-Yair, Raz
Cheng, Saifeng
Aguilera-Castrejon, Alejandro http://orcid.org/0000-0002-1339-7778
Reines, Netta
Orenbuch, Ayelet-Hashahar
Lifshitz, Aviezer http://orcid.org/0000-0002-8458-9507
Chen, Dong-Yuan http://orcid.org/0000-0003-2179-2847
Elowitz, Michael B. http://orcid.org/0000-0002-1221-0967
Zernicka-Goetz, Magdalena
Hanna, Jacob H. http://orcid.org/0000-0003-2042-9974
Tanay, Amos http://orcid.org/0000-0001-9419-3824
Stelzer, Yonatan http://orcid.org/0000-0001-9207-1479
Article History
Received: 12 July 2022
Accepted: 9 August 2024
First Online: 18 September 2024
Competing interests
: M.B.E. is a co-founder, scientific advisory board member, or consultant at TeraCyte, Primordium Labs, Spatial Genomics, and Asymptote Genetic Medicines. J.H.H. is an inventor on patents and patent applications related to ex utero embryogenesis, and a co-founder and chief scientific advisor of Renewal Bio, which has licensed the latter technologies. The other authors declare no competing interests.